[b]NSAV Historical February Running chart[/b]
[IMG]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png[/IMG]
[url]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png[/url] Chart Direct Link
[b]NSAV INFO![/b]
Share Structure:
Market Value1 $248,720 a/o Jan 25, 2013
Shares Outstanding 621,801,136 a/o Jan 23, 2013
Float 500,721,621 a/o Jan 23, 2013
Authorized Shares 1,000,000,000 a/o Jan 23, 2013
Par Value 0.001
[url]http://www.otcmarkets.com/stock/NSAV/company-info[/url] OTC markets Direct Link
[b]4 Day Historical Volume![/b]
Jan 22, 2012 Volume: 4,710,940
Jan 23, 2012 Volume: 13,864,667
Jan 24, 2012 Volume: 58,861,564 (VERT was taken out Jan 24, 2012)
Jan 25, 2012 Volume: 61,966,220 (VNDM was taken out Jan 25, 2012)
[b]Volume is increasing! Conversions are now at an end!![/b]
[b]Hystorical September 26, 2012 E-mail Correspondence between CEO
of NSAV David Saltrelli and another Investor![/b]
[quote]CEO ANSWERS E-MAIL:
Question: What are the goals for this company moving forward? I don't see any definitive goals set for the company on the website, reaching millions of buyers is not exactly an affirmative answer for stock holders when looking to invest in the stock.
ANSWER: NSAV sells Savings Certificates. Our goal is to sell millions of them.
Go to our website and click on the 4 sections and follow the links and you will see how we make the respective sales.
We expect to be profitable in October and then we expect to double profits every month for the next 6 - 10 months. The 6 month profit goal is $1,000,000 per month from selling Savings Certificates.
Question: was just concerned I have not heard or seen any follow ups. Is FamilyCoOp going to run ads? Also, who is selling the sales certificates if you don't mind me asking? And by profitable in October do you mean the 3rd quarter results that are due out will reveal a strong quarter?
ANSWER NSL sells through Affiliate Partners and also direct.
Family Savings CoOp advertises their program
Our quarter ended 8/31/12 and the Q should be out around 10/15/12
October is in this current quarter which will end November 30th.
Question: what is going on with the stock, Can you help the stock by saying something?
Answer: Nothing we can do at the current time. Asher and Southridge are converting their loans into stock and selling the stock in the market.
Nothing I can say to help at this time.
We are selling everyday and we anticipate being profitable in October. That is what we are concentrating all our efforts on.
Question: Does Asher and Southridge converting their loans into stock and selling the stock in the market help the stock down the road I would hope?
Answer:
By converting loans into stock it pays off the loans and the company becomes debt free. Then with profits and no debt the stock should go up, but nothing is guaranteed. All the best,
David Saltrelli, President
Net Savings Link, Inc. | Stock Symbol: NSAV
(727) 442 2600 (Office) | (727) 482 5800 (Cell)
www.NetSavingsLink.com | LinkedIn
Fundraising | Incentives | Joint Ventures | Business Opportunities [/quote]
[b][u]E-Mail Correspondence between CEO of NSAV David Saltrellli and myself![/u][/b]
[quote]On Jan 25, 2013, at 3:38 PM, David Saltrelli <david@netsavingslink.com> wrote:
Alex,
>
> Our 10K, year end report, is due February 28th. All info on conversions and sales will be in there as well are information on what has occurred during the last 60 days. Sorry, but you will have to wait for that report. We may put out news sooner via a press release. We cannot give information out to individual shareholders.
>
>
> All the best,
>
>
>
> David Saltrelli, President
>
> Net Savings Link, Inc. | Stock Symbol: NSAV
>
> (727) 442 2600 (Office) | (727) 482 5800 (Cell)
>
> www.NetSavingsLink.com | LinkedIn
>
> Fundraising | Incentives | Joint Ventures | Business Opportunities
>
>
>
> On Fri, Jan 25, 2013 at 3:07 PM, Alex Woods- Leo <alexmwoodsleo@gmail.com> wrote:
>
> David
>
> My name is Alex Leo and i am a current shareholder and was wondering how many conversions are left. Seems theres still some shares to be sold. We took out VERT yesterday and we are stuck on VNDM right now. However many of us are wondering about how many more shares are to be dumped?
>
> If this can be answered this would be great. Also in an e-mail to a fellow investor back in September you had stated that NSAV should be putting out financials around Feb 28. is that still the case? If so does it still look like NSAV may be posting Debt Free status?
>
> Long and Strong
>
> Alex Leo
[/quote]
NSAV Historical February Running chart
Top 10 Most Recent News Articles
Resorts World NYC Unveils Luxe High-Roller Room
New Frontier for New York's Gaming Scene The glitz and glamour of high-roller gaming just found a new home in the heart of Queens. Resorts World New York City (RWNYC), which has been turning heads for over a decade, has now cranked the luxe up a notch with the introduction of its International Room. This isn't just any room, folks; we're talking about a high-limit gaming...
Continue Reading
Voter Power Flexes with Early Voting Celebrations
Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...
Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles
Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...
Continue Reading
Rakuten Medical's Long-Term Data Shows Promise
This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...
Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord
A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...
Continue Reading
Venture Dock Fosters Global Startup Ecosystems
Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...
Continue Reading
D-Wave Investors Face Pressure Ahead of December 15
Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...
Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan
Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...
Continue Reading
California Waste Solutions: Investing in Vietnam's Future
Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....
Continue Reading
Kahn Swick & Foti Questions Valaris Transocean Deal
Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...
Continue ReadingTop 5 Most Recently Viewed Articles
Nasdaq Inc. Reveals Strategy for Cash Tender Offers on Debt
Nasdaq Inc. Cash Tender Offers Overview Nasdaq, Inc. (NASDAQ: NDAQ) has made headlines with its recent announcements regarding cash tender offers for up to $218 million of its outstanding debt securities. This initiative involves a strategy to repurchase existing Notes, which consist of senior notes due in 2028, 2034, and 2052. The company has decided to enhance the...
Continue Reading
Ultima Markets Partners with Inter for Exciting New Venture
Ultima Markets Partners with Inter in Asia Ultima Markets has officially joined forces with FC Internazionale Milano (Inter) as their Official Regional Partner in Asia. This partnership marks a significant step in Ultima Markets' growth strategy, symbolizing a unique collaboration that merges the world of finance with the excitement of football, creating a distinctive...
Continue Reading
Ribo Secures EMA Orphan Drug Status for RBD1016 Against HDV
Ribo Life Science Gains Important EMA Approval BEIJING and GOTHENBURG, Sweden – In a significant advancement for the medical community, Suzhou Ribo Life Science Co., Ltd. along with Ribocure Pharmaceuticals AB has achieved a noteworthy milestone. The European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) for RBD1016, a promising therapeutic aimed at...
Continue Reading
Projected Growth of the Wood Pellets Market Driving Investment
Overview of the Wood Pellets Market Growth The latest insights reveal that the wood pellets market is on a trajectory to significantly grow, with projections indicating it could reach an impressive valuation of USD 20.5 billion. This growth is primarily fueled by the rising global demand for renewable energy sources, a trend that is transforming the energy landscape. Key...
Continue Reading
Surge Copper Corp. Engages Investors in Virtual Conference
Engagement Opportunity with Surge Copper Corp. Surge Copper Corp. (TSXV: SURG, OTCQB: SRGXF) is set to engage with investors at an upcoming virtual investor conference. This event, held through VirtualInvestorConferences.com, will be hosted by Leif Nilsson, the company's CEO, providing a platform for potential investors to learn more about Surge's ongoing projects focused...
Continue Reading